Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Condition:   Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Intervention:   Drug: dualCAR-NK19/70 cell Sponsor:   Aibin Liang，MD，Ph.D. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials